Acquired by 22nd Century Group (NASDAQ:XXII) Acquires GVB Biopharma: Stock Jumps

May 16, 2022

22nd Century Group Inc. (NASDAQ:XXII) has acquired privately held GVB Biopharma, which is a contract development and manufacturing organization that is supposedly one of the biggest providers of hemp-derived active ingredients for the pharmaceutical and consumer goods industries globally, based on total tonnage. Trading Data On Friday, XXII stock surged 7% to $1.68 with more than 3.26 million shares, compared to its average volume of 1.56 million shares. The stock…


5 Cannabis Penny Stocks To Radar: RLBD, MNJA, MSRT, MBII, XXII

February 23, 2022

Cannabis is finding its way onto store shelves and online carts in a growing number of products. The cannabis market continues to find ways to deliver CBD, hemp, and cannabis benefits to consumers through traditional products.  Athletic performance brands like Real Brands’ (OTCMKTS:RLBD) Phaze Sports creates a line of CBD and hemp-infused products. Phaze targets performance and rest for athletes ready for an alternative to the traditional prescriptions and OTC…